Guidelines for the use and management of long-acting injectable antipsychotics in serious mental illness
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-244X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Guidelines for the use and management of long-acting injectable antipsychotics in serious mental illness ; volume:13 ; number:1 ; day:20 ; month:12 ; year:2013 ; pages:1-17 ; date:12.2013
BMC psychiatry ; 13, Heft 1 (20.12.2013), 1-17, 12.2013
- Urheber
-
Llorca, Pierre Michel
- Beteiligte Personen und Organisationen
-
Abbar, Mocrane
Courtet, Philippe
Guillaume, Sebastien
Lancrenon, Sylvie
Samalin, Ludovic
SpringerLink (Online service)
- DOI
-
10.1186/1471-244X-13-340
- URN
-
urn:nbn:de:1111-2016030435384
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:34 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Llorca, Pierre Michel
- Abbar, Mocrane
- Courtet, Philippe
- Guillaume, Sebastien
- Lancrenon, Sylvie
- Samalin, Ludovic
- SpringerLink (Online service)
Ähnliche Objekte (12)
The Use of Long-Acting Injectable Antipsychotics in Schizophrenia
Pharmacokinetic Characteristics of Long-Acting Injectable Antipsychotics for Schizophrenia: An Overview
Attitudes of European physicians towards the use of long-acting injectable antipsychotics
Long-Acting Injectable Antipsychotics in a Prescription Claims Data Source: A Validation Study
Long-acting injectable atovaquone nanomedicines for malaria prophylaxis
Long-Acting Injectable Antipsychotics in Schizophrenia: Literature Review and Practical Perspective, with a Focus on Aripiprazole Once-Monthly
Cost Effectiveness of Paliperidone Long-Acting Injectable Versus Other Antipsychotics for the Maintenance Treatment of Schizophrenia in France
What Role for Long-Acting Injectable Antipsychotics in Managing Schizophrenia Spectrum Disorders in Children and Adolescents? A Systematic Review
All-cause mortality risk in long-acting injectable versus oral antipsychotics in schizophrenia: a systematic review and meta-analysis
Patient and prescriber perspectives on long-acting injectable (LAI) antipsychotics and analysis of in-office discussion regarding LAI treatment for schizophrenia
Pharmacokinetics of an injectable long-acting formulation of doxycycline hyclate in dogs
Patients’ satisfaction with long-acting injectable somatostatin analog therapy for neuroendocrine tumors
The Use of Long-Acting Injectable Antipsychotics in Schizophrenia
Pharmacokinetic Characteristics of Long-Acting Injectable Antipsychotics for Schizophrenia: An Overview
Attitudes of European physicians towards the use of long-acting injectable antipsychotics
Long-Acting Injectable Antipsychotics in a Prescription Claims Data Source: A Validation Study
Long-acting injectable atovaquone nanomedicines for malaria prophylaxis
Long-Acting Injectable Antipsychotics in Schizophrenia: Literature Review and Practical Perspective, with a Focus on Aripiprazole Once-Monthly
Cost Effectiveness of Paliperidone Long-Acting Injectable Versus Other Antipsychotics for the Maintenance Treatment of Schizophrenia in France
What Role for Long-Acting Injectable Antipsychotics in Managing Schizophrenia Spectrum Disorders in Children and Adolescents? A Systematic Review
All-cause mortality risk in long-acting injectable versus oral antipsychotics in schizophrenia: a systematic review and meta-analysis
Patient and prescriber perspectives on long-acting injectable (LAI) antipsychotics and analysis of in-office discussion regarding LAI treatment for schizophrenia
Pharmacokinetics of an injectable long-acting formulation of doxycycline hyclate in dogs
Patients’ satisfaction with long-acting injectable somatostatin analog therapy for neuroendocrine tumors
The Use of Long-Acting Injectable Antipsychotics in Schizophrenia
Pharmacokinetic Characteristics of Long-Acting Injectable Antipsychotics for Schizophrenia: An Overview
Attitudes of European physicians towards the use of long-acting injectable antipsychotics
Long-Acting Injectable Antipsychotics in a Prescription Claims Data Source: A Validation Study
Long-acting injectable atovaquone nanomedicines for malaria prophylaxis
Long-Acting Injectable Antipsychotics in Schizophrenia: Literature Review and Practical Perspective, with a Focus on Aripiprazole Once-Monthly
Cost Effectiveness of Paliperidone Long-Acting Injectable Versus Other Antipsychotics for the Maintenance Treatment of Schizophrenia in France
What Role for Long-Acting Injectable Antipsychotics in Managing Schizophrenia Spectrum Disorders in Children and Adolescents? A Systematic Review
All-cause mortality risk in long-acting injectable versus oral antipsychotics in schizophrenia: a systematic review and meta-analysis
Patient and prescriber perspectives on long-acting injectable (LAI) antipsychotics and analysis of in-office discussion regarding LAI treatment for schizophrenia
Pharmacokinetics of an injectable long-acting formulation of doxycycline hyclate in dogs